Shorter Radiation Courses Effective for Post-Mastectomy Breast Cancer Patients, Study Finds

A new study shows that mastectomy patients can safely receive a shorter course of radiation therapy, reducing treatment time by half without compromising reconstructive surgery. The study involved 650 patients and found that both shorter and standard courses had similar complication and recurrence rates. The findings provide robust data supporting the safety and effectiveness of short-course radiation.

Mastectomy patients can now benefit from a shorter course of radiation therapy without risking complications in their breast reconstruction, according to a new study. Conducted by Dr. Matthew Poppe's team from the University of Utah, the study followed 650 patients who received either the conventional five-week radiation schedule or a condensed three-week regimen.

The study presented at the American Society for Radiation Oncology meeting found that complication rates were comparable between the two groups, despite concerns that higher daily doses might increase side effects. "The results show we can safely reduce treatment time to three weeks," said Dr. Poppe.

Additionally, this reduction in treatment time did not lead to higher recurrence rates, with 1.5% in the shorter-course group versus 2.3% in the standard group. This breakthrough offers a promising alternative for patients and paves the way for broader acceptance of short-course radiation post-mastectomy.

(With inputs from agencies.)